Hepatitis B, C and TTV virus infection in highly trained athletes

Melnikova LI1, Kozhanova TV2, Ilchenko LYu2,3, Morozov IA2, Soboleva NV2, Nguyen Thi-Hanh3, Kruglova IV4, Gordeychuk IV2
About authors

1 Clinical Hospital № 85 of Federal Medical-Biological Agency, Moscow, Russia

2 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, Moscow, Russia

3 Pirogov Russian National Research Medical University, Moscow, Russia

4 Federal Research and Clinical Center for Sports Medicine and Rehabilitation of the Federal Medical Biological Agency, Moscow, Russia

Correspondence should be addressed: Lubov I. Melnikova
Kashirskoe shosse, 13G, Moscow, 115230, Russia; ur.liam@561lem

About paper

Author contribution: Melnikova LI, Kruglova IV — collection of material, data analysis; Kozhanova TV — identification of markers of hepatitis virus infection, manuscript writing; Ilchenko LYu — research design development, data analysis; Morozov IA — research design, manuscript editing; Soboleva NV — identification of the hepatitis virus infection markers, statistical data processing; Nguyen Thi-Hanh — literature analysis; Gordeychuk IV — manuscript editing, approval of the final version of the article.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Clinical Hospital No. 85 of FMBA of Russia (protocol № 157 dated September 19, 2018). All subjects submitted the informed consent to blood sampling, identification of the hepatitis virus infection markers, and publication of results.

Received: 2022-02-16 Accepted: 2022-03-05 Published online: 2022-03-22
Table 1. Questionnaire for highly trained athletes
Note: HAV — hepatitis A virus, HBV — hepatitis B virus.
Table 2. Characteristics of athletes by gender and athletic discipline
Table 3. Markers of hepatitis virus infection in athletes